AIM ImmunoTech (UK) Analysis

0A4Y Stock   0.23  0.01  4.55%   
AIM ImmunoTech is overvalued with Real Value of 0.2 and Hype Value of 0.22. The main objective of AIM ImmunoTech stock analysis is to determine its intrinsic value, which is an estimate of what AIM ImmunoTech is worth, separate from its market price. There are two main types of AIM ImmunoTech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AIM ImmunoTech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AIM ImmunoTech's stock to identify patterns and trends that may indicate its future price movements.
The AIM ImmunoTech stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. AIM ImmunoTech is usually not traded on Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, May Day Bank Holiday, Spring Bank Holiday ( 2025 ). AIM Stock trading window is adjusted to Europe/London timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy AIM Stock please use our How to Invest in AIM ImmunoTech guide.

AIM Stock Analysis Notes

About 14.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 0.4. AIM ImmunoTech had not issued any dividends in recent years. The entity had 0.022727:1 split on the 11th of June 2019. For more info on AIM ImmunoTech please contact Esq JD at 352 448 7797 or go to https://aimimmuno.com.

AIM ImmunoTech Quarterly Total Revenue

33,000

AIM ImmunoTech Investment Alerts

AIM ImmunoTech generated a negative expected return over the last 90 days
AIM ImmunoTech has some characteristics of a very speculative penny stock
AIM ImmunoTech has high historical volatility and very poor performance
AIM ImmunoTech has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 201 K. Net Loss for the year was (19.45 M) with loss before overhead, payroll, taxes, and interest of (715 K).
Latest headline from news.google.com: AIM - AIM ImmunoTech Inc. Latest Stock News Market Updates - StockTitan

AIM ImmunoTech Thematic Classifications

In addition to having AIM ImmunoTech stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
IT Idea
IT
Information technology and IT services

Management Efficiency

The company has return on total asset (ROA) of (0.8004) % which means that it has lost $0.8004 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5479) %, meaning that it generated substantial loss on money invested by shareholders. AIM ImmunoTech's management efficiency ratios could be used to measure how well AIM ImmunoTech manages its routine affairs as well as how well it operates its assets and liabilities. At this time, AIM ImmunoTech's Total Assets are comparatively stable compared to the past year. Total Current Assets is likely to gain to about 60.6 M in 2024, whereas Other Current Assets are likely to drop slightly above 611.2 K in 2024.
Leadership effectiveness at AIM ImmunoTech is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin
(73.88)
Beta
(0.36)
Return On Assets
(0.80)
Return On Equity
(1.55)

Technical Drivers

As of the 30th of November, AIM ImmunoTech shows the Risk Adjusted Performance of (0.09), mean deviation of 2.71, and Coefficient Of Variation of (792.04). AIM ImmunoTech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm AIM ImmunoTech variance, treynor ratio, and the relationship between the standard deviation and information ratio to decide if AIM ImmunoTech is priced adequately, providing market reflects its regular price of 0.23 per share.

AIM ImmunoTech Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AIM ImmunoTech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AIM ImmunoTech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

AIM ImmunoTech Predictive Daily Indicators

AIM ImmunoTech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AIM ImmunoTech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

AIM ImmunoTech Forecast Models

AIM ImmunoTech's time-series forecasting models are one of many AIM ImmunoTech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AIM ImmunoTech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About AIM Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how AIM ImmunoTech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AIM shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AIM ImmunoTech. By using and applying AIM Stock analysis, traders can create a robust methodology for identifying AIM entry and exit points for their positions.
AIM ImmunoTech is entity of United Kingdom. It is traded as Stock on LSE exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AIM ImmunoTech to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Additional Tools for AIM Stock Analysis

When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.